/
Your selections:
Real-world treatment patterns and outcomes for patients with CLL using the Australian pharmaceutical benefits scheme (PBS) dataset
- Tam, Constantine, Zhao, Fei-Li, Azam, Safee, Li, Shu Chuen, Tang, Boxiong
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation
- Joshi, Maansi, Taper, John, Huang, Gillian, Hertzberg, Mark, Forsyth, Cecily, Rowlings, Philip, Campbell, Philip, Crispin, Philip, Harvey, Michael, Underhill, Craig, Bayley, Angela, Byth, Karen
Are you sure you would like to clear your session, including search history and login status?